Pulse.

a daily field guide to health research that matters

◆ Console

‹ Mon · 9 Nov 2026
Promising but preliminary

Label-free machine learning detects a multi-cancer signal in a noninvasive urine and plasma metabolite panel: a case-control study.

We assessed how well a four-metabolite panel separates cancer cases from controls across eight cancer types, whether this separation is detectable without outcome labels, and how performance translates to realistic prevalence. We evaluated survival association and predictive values across prevalence.

We assessed how well a four-metabolite panel separates cancer cases from controls across eight cancer types, whether this separation is detectable without outcome labels, and how performance translates to realistic prevalence. We evaluated survival association and predictive values across prevalence.

What the study was

Study design
Cohort study
Population
n=4105
Sample size
n=4105
Category
Other
Maturity
Exploratory
Journal
medRxiv : the preprint server for health sciences

Why it surfaced

⚪ PROMISING_PRELIMINARY — Promising but preliminary; Watchlist: Early cancer detection (liquid biopsy, ctDNA, cfDNA); Design: Cohort study; species: human

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.